The drugmaker’s application follows its Jan. 29 report in which it said the vaccine had a 66 per cent rate of preventing infections in its large global trial. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.